Mark Berman
Directeur/Bestuurslid bij Oriental Yeast Co., Ltd.
Oorsprong van het eerstegraads netwerk van Mark Berman
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Oriental Yeast Co., Ltd.
 Oriental Yeast Co., Ltd. Food: Major DiversifiedConsumer Non-Durables Oriental Yeast Co., Ltd. engages in the manufacture and sale of yeast, raw materials for bread manufacturing, confectionery, noodles, various feeds, biochemistry, and toxicity studies on medicines, food, and others. It is also engages in sales of laboratory animals. Its operations are carried out through the following segments: Food Business and Bioindustry Business. The Food Business segment develops and supplies food ingredients including yeast, flour paste, and mayonnaise. The Bioindustry Business segment produces diagnostic reagent raw materials or reagent in research use, including recombinant enzymes and human proteins. The company was founded on June 30, 1929 and is headquartered in Tokyo, Japan.
15
| Subsidiary | Food: Major Diversified | 15 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mark Berman via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| NISSHIN SEIFUN GROUP INC. | Agricultural Commodities/Milling | Director/Board Member Chief Administrative Officer Corporate Officer/Principal Director of Finance/CFO Sales & Marketing Corporate Officer/Principal Director of Finance/CFO | |
| INA RESEARCH INC. | Miscellaneous Commercial Services | Director/Board Member | |
Kohjin BIO Co., Ltd.
 Kohjin BIO Co., Ltd. BiotechnologyHealth Technology Kohjin Bio Co., Ltd. engages in the manufacture and sale of animal blood, serums, tissue culture media and other products. It operates through the following business segments. Tissue Culture Business, Microbiology Business and Cell Processing Business. The Tissue Culture business segment engages in the manufactures, and sale of tissue culture media, including serum free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions. The company was founded by Takato Nakamura in April 1981 and is headquartered in Sakado, Japan. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Japan | 4 |
Sectoraal
| Process Industries | 2 |
| Commercial Services | 2 |
| Health Technology | 2 |
Operationeel
| Director/Board Member | 18 |
| Corporate Officer/Principal | 8 |
| Comptroller/Controller/Auditor | 4 |
| Sales & Marketing | 4 |
| President | 2 |
Sterkste connecties
- Beurs
- Insiders
- Mark Berman
- Bedrijfsconnecties
